The lipopolysaccharide core of Brucella abortus acts as a shield against innate immunity recognition.

Search TravelDoctorOnline

Authors: Conde-Álvarez R,Arce-Gorvel V,Iriarte M,Manček-Keber M,Barquero-Calvo E,Palacios-Chaves L,Chacón-Díaz C,Chaves-Olarte E,Martirosyan A,von Bargen K,Grilló MJ,Jerala R,Brandenburg K,Llobet E,Bengoechea JA,Moreno E,Moriyón I,Gorvel JP,
Address: Institute for Tropical Health and Departamento de Microbiología y Parasitología, Universidad de Navarra, Pamplona, Spain.
Journal: PLoS Pathog.


Publication: 2012;8(5):e1002675. doi: 10.1371/journal.ppat.1002675. Epub 2012 May 10.
Free Text: The lipopolysaccharide core of Brucella abortus acts as a shield against innate immunity recognition.

abstract

innate immunity recognizes bacterial molecules bearing pathogen-associated molecular patterns to launch inflammatory responses leading to The activation of adaptive immunity. However, the lipopolysaccharide (LPS) of the gram-negative bacterium Brucella lacks a marked pathogen-associated molecular pattern, and it has been postulated that this delays the development of immunity, creating a gap that is critical for the bacterium to reach the intracellular replicative niche. We found that a B. abortus mutant in the wadC gene displayed a disrupted LPS core while keeping both the LPS O-polysaccharide and lipid A. In mice, the wadC mutant induced proinflammatory responses and was attenuated. In addition, it was sensitive to killing by non-immune serum and bactericidal peptides and did not multiply in dendritic cells being targeted to lysosomal compartments. In contrast to wild type B. abortus, the wadC mutant induced dendritic cell maturation and secretion of pro-inflammatory cytokines. All these properties were reproduced by the wadC mutant purified LPS in a TLR4-dependent manner. Moreover, the core-mutated LPS displayed an increased binding to MD-2, the TLR4 co-receptor leading to subsequent increase in intracellular signaling. Here we show that Brucella escapes recognition in early stages of infection by expressing a shield against recognition by innate immunity in its LPS core and identify a novel virulence mechanism in intracellular pathogenic gram-negative bacteria. These results also encourage for an improvement in the generation of novel bacterial vaccines.



Related Articles
The differential interaction of Brucella and ochrobactrum with innate immunity reveals traits related to the evolution of stealthy pathogens.
PLoS One. 2009
The differential interaction of Brucella and ochrobactrum with innate immunity reveals traits related to the evolution of stealthy pathogens.
Barquero-Calvo E, Conde-Alvarez R, Chacón-Díaz C, Quesada-Lobo L, Martirosyan A, Guzmán-Verri C, Iriarte M, Mancek-Keber M, Jerala R, Gorvel JP, et al. PLoS One. 2009 Jun 16; 4(6):e5893. Epub 2009 Jun 16.
The lipopolysaccharide of Brucella abortus BvrS/BvrR mutants contains lipid A modifications and has higher affinity for bactericidal cationic peptides.
J Bacteriol. 2005
The lipopolysaccharide of Brucella abortus BvrS/BvrR mutants contains lipid A modifications and has higher affinity for bactericidal cationic peptides.
Manterola L, Moriyón I, Moreno E, Sola-Landa A, Weiss DS, Koch MH, Howe J, Brandenburg K, López-Goñi I. J Bacteriol. 2005 Aug; 187(16):5631-9.
Role of Toll-like receptor 4 in induction of cell-mediated immunity and resistance to Brucella abortus infection in mice.
Infect Immun. 2004
Role of Toll-like receptor 4 in induction of cell-mediated immunity and resistance to Brucella abortus infection in mice.
Campos MA, Rosinha GM, Almeida IC, Salgueiro XS, Jarvis BW, Splitter GA, Qureshi N, Bruna-Romero O, Gazzinelli RT, Oliveira SC. Infect Immun. 2004 Jan; 72(1):176-86.
Review Innate immune encounters of the (Type) 4th kind: Brucella.
Cell Microbiol. 2010
Review Innate immune encounters of the (Type) 4th kind: Brucella.
de Jong MF, Rolán HG, Tsolis RM. Cell Microbiol. 2010 Sep 1; 12(9):1195-202. Epub 2010 Jul 28.
Review The innate immune response against Brucella in humans.
Vet Microbiol. 2002
Review The innate immune response against Brucella in humans.
Dornand J, Gross A, Lafont V, Liautard J, Oliaro J, Liautard JP. Vet Microbiol. 2002 Dec 20; 90(1-4):383-94.
Brucella β 1,2 cyclic glucan is an activator of human and mouse dendritic cells.
PLoS Pathog. 2012
Brucella β 1,2 cyclic glucan is an activator of human and mouse dendritic cells.
Martirosyan A, Pérez-Gutierrez C, Banchereau R, Dutartre H, Lecine P, Dullaers M, Mello M, Pinto Salcedo S, Muller A, Leserman L, et al. PLoS Pathog. 2012; 8(11):e1002983. Epub 2012 Nov 15.
Comparative genomics of early-diverging Brucella strains reveals a novel lipopolysaccharide biosynthesis pathway.
MBio. 2012
Comparative genomics of early-diverging Brucella strains reveals a novel lipopolysaccharide biosynthesis pathway.
Wattam AR, Inzana TJ, Williams KP, Mane SP, Shukla M, Almeida NF, Dickerman AW, Mason S, Moriyón I, O'Callaghan D, et al. MBio. 2012; 3(5):e00246-12. Epub 2012 Aug 28.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.